Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.2B | 2.2B | 2.1B |
Cost of revenue | 537M | 539M | 530M | 511M |
Gross profit | 1.7B | 1.7B | 1.6B | 1.6B |
Operating expense | ||||
Research & development | 663M | 674M | 647M | 649M |
Selling general and admin | 835M | 839M | 818M | 814M |
Other operating expenses | — | — | — | — |
Operating income | 205M | 159M | 165M | 111M |
Non operating interest income | ||||
Income | 93M | 83M | 86M | 88M |
Expense | 29M | 28M | 29M | 28M |
Other income expense | -166M | -94M | 5M | -3M |
Pretax income | 103M | 120M | 227M | 168M |
Tax provision | 35M | 26M | 34M | 36M |
Net income | 68M | 94M | 193M | 132M |
Basic EPS | 0.3 | — | 0.7 | 0.5 |
Diluted EPS | 0.3 | — | 0.7 | 0.5 |
Basic average shares | 266.5M | — | 265.4M | 265.3M |
Diluted average shares | 270.3M | — | 268.5M | 267.9M |
EBITDA | 382M | 239M | 337M | 275M |
Net income from continuing op. | 68M | 94M | 193M | 132M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |